Innovent Biologics Inc.

OTC: IVBXF · Real-Time Price · USD
12.70
0.46 (3.76%)
At close: Aug 21, 2025, 3:46 PM
12.70
0.00%
After-hours: Aug 21, 2025, 04:00 PM EDT

Innovent Biologics Cash Flow Statement

Financials in CNY. Fiscal year is January - December.
Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
Net Income
-94.63M -1.28B -1.03B -1.37B -2.18B -2.68B -2.73B -1.39B
Depreciation & Amortization
198.67M 381.81M 370.77M 339.48M 276.79M 237.6M 202.17M 118.7M
Stock-Based Compensation
556.52M 644.93M 574.2M 435.31M 469.49M 523.71M 501.57M 486.88M
Other Working Capital
-25.21M 550.61M 566.77M -411.58M -313.45M 858.87M 864.46M 444.09M
Other Non-Cash Items
-757.07M 100.82M -264.33M -1.06B -460.11M -185.08M 272.01M 985.89M
Deferred Income Tax
n/a n/a 96.89M -761.46M -757.24M 101.11M 822.5M 882.35M
Change in Working Capital
-119.13M 708.89M 495.09M -85.42M -25.7M 283.34M -271.84M -777.21M
Operating Cash Flow
-215.63M 555.07M 147.81M -1.73B -1.92B -1.82B -2.02B -579.52M
Capital Expenditures
-699.51M -1.22B -1.12B -1.07B -896.9M -1.15B -1.07B -803.22M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
145.82M -1.06B 120.72M -23.75M -538.29M -955.41M -1.63B -3.65B
Investing Cash Flow
-553.69M -2.28B -998.66M -1.09B -1.44B -2.1B -2.7B -4.45B
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-260.81M 2.08B 2.59B 2.91B 2.89B 723.44M 5B 7.23B
Financial Cash Flow
-260.81M 2.08B 2.59B 2.91B 2.89B 723.44M 5B 7.23B
Net Cash Flow
-2.23B 190.85M 864.76M -9.89M -171.62M -1.56B -539.5M 166.96M
Free Cash Flow
-915.15M -665.93M -971.58M -2.8B -2.82B -2.96B -3.09B -1.38B